Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    ST101

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ProBioGen & Spica Therapeutic Collaborate on GlymaxX-Enhanced CLD
    ProBioGen & Spica Therapeutic Collaborate on GlymaxX-Enhanced CLD

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/probiogen-and-spica-therapeutics-announce-collaboration-on-glymaxx-enhanced-cld-for-spica-s-clinical-development-candidate-st101

    PHARMIWEB
    11 Dec 2025
    Share Share
    Sapience's ST101 Shows Positive GBM Data, Biomarkers In ASCO Oral Session
    Sapience's ST101 Shows Positive GBM Data, Biomarkers In ASCO Oral Session

    01 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-presents-positive-clinical-and-biomarker-data-from-st101-phase-2-study-in-gbm-at-asco-2024-in-oral-presentation-302161146.html

    PR NEWSWIRE
    01 Jun 2024
    Share Share
    Sapience St101 Glioblastoma Featured: Phase 2 Clinical Biomarkers Asco
    Sapience St101 Glioblastoma Featured: Phase 2 Clinical Biomarkers Asco

    23 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sapience-therapeutics-to-showcase-clinical-and-biomarker-data-from-st101-phase-2-study-in-gbm-at-asco-2024-302154660.html

    PR NEWSWIRE
    23 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.